Eli Lilly and Company (LLY) - Financial and Strategic SWOT Analysis Review

Transcription

1 Eli Lilly and Company (LLY) - Financial and Strategic SWOT Analysis Review

2 Eli Lilly and Company (LLY) - Financial and Strategic SWOT Analysis Review BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0) or reportstore@bioportfolio.com 2

3 Eli Lilly and Company (LLY) - Financial and Strategic SWOT Analysis Review Eli Lilly and Company (LLY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description A detailed description of the company s operations and business divisions. - Corporate strategy Analyst s summarization of the company s business strategy. - SWOT Analysis A detailed analysis of the company s strengths, weakness, opportunities and threats. - Company history Progression of key events associated with the company. - Major products and services A list of major products, services and brands of the company. - Key competitors A list of key competitors to the company. - Key employees A list of the key executives of the company. - Executive biographies A brief summary of the executives employment history. - Key operational heads A list of personnel heading key departments/functions. - Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history. Highlights Eli Lilly and Company (Lilly) is a healthcare company that discovers, develops and markets human and animal healthcare products. The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, critical care, men's health and musculoskeletal problems. It also provides pet medicine, food-safety products and companion animal health products, besides services to the food animal industry. Lilly also has mid-to-late stage pipeline portfolio for conditions such as diabetes, cancer, neurological problems and autoimmune disorders. The company distributes human pharmaceutical and animal health products through independent wholesale distributors. It also promotes its products through sales representatives and marketing agreements with other pharmaceutical companies. The company offers its products in the US, Europe, Japan and Other foreign countries. Lilly is headquartered in Indianapolis, Indiana, the US. 3

4 Eli Lilly and Company Key Recent Developments Mar 02,2017: Lilly Announces Changes In Senior Management Feb 09,2017: Carolyn R. Bertozzi, Ph.D., Elected To Lilly Board Of Directors Jan 31,2017: Lilly Reports Fourth-Quarter And Full-Year 2016 Results Jan 23,2017: Inovalon Announces Agreement With Boehringer Ingelheim to Support Outcome-Based Contracting Jan 11,2017: New Drug Formulary Will Help Expedite Use of Agents in Clinical Trials Key benefits of buying this profile include: You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors. Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios. Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. Note: Some sections may be missing if data is unavailable for the company Additional Details Publisher : Global Data Reference : GDPH4003FSA Number of Pages : 77 4

5 Report Format : PDF Publisher Information : 5

6 Table Of Contents for Eli Lilly and Company (LLY) - Financial and Strategic SWOT Analysis Review [Report Updated: ] Table of Contents Table of Contents 3List of Tables 5List of Figures 5Section 1 - About the Company 6Eli Lilly and Company - Key Facts 6Eli Lilly and Company - Key Employees 7Eli Lilly and Company - Key Employee Biographies 9Eli Lilly and Company - Major Products and Services 10Eli Lilly and Company - Pharmaceutical Pipeline Products Data 13Eli Lilly and Company, Pipeline Products by Therapy Area 13Eli Lilly and Company, Pipeline Products by Development Phase 15Eli Lilly and Company - History 16Eli Lilly and Company - Company Statement 28Eli Lilly and Company - Locations And Subsidiaries 30Head Office 30Other Locations & Subsidiaries 30Joint Venture 38Section 2 Company Analysis 39Eli Lilly and Company - Business Description 39Business Description - Animal Health Products 39Animal Health Products - Overview 39Animal Health Products - Financials 39Business Description - Human Pharmaceutical Products 39Human Pharmaceutical Products - Overview 39Human Pharmaceutical Products - Financials 40Eli Lilly and Company - Corporate Strategy 41Eli Lilly and Company - SWOT Analysis 42SWOT Analysis - Overview 42Eli Lilly and Company - Strengths 42Eli Lilly and Company - Weaknesses 43Eli Lilly and Company - Opportunities 44Eli Lilly and Company - Threats 46Eli Lilly and Company - Key Competitors 47Section 3 Company Financial Ratios 48Financial Ratios - Capital Market Ratios 48Financial Ratios - Annual Ratios 49Performance Chart 51Financial Performance 51Financial Ratios - Interim Ratios 52Financial Ratios - Ratio Charts 53Section 4 Company s Lifesciences Financial Deals and Alliances 54Eli Lilly and Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD Eli Lilly and Company, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD Eli Lilly and Company, Recent Deals Summary 56Section 5 Company s Recent Developments 57Mar 02, 2017: Lilly Announces Changes In Senior Management 57Feb 09, 2017: Carolyn R. Bertozzi, Ph.D., Elected To Lilly Board Of Directors 58Jan 31, 2017: Lilly Reports Fourth-Quarter And Full-Year 2016 Results 59Jan 23, 2017: Inovalon Announces Agreement With Boehringer Ingelheim to Support Outcome-Based Contracting 65Jan 11, 2017: New Drug Formulary Will Help Expedite Use of Agents in Clinical Trials 66Jan 05, 2017: Lilly To Adjust Organization And Leadership Structure To Better Align With Growth Opportunities 67Jan 05, 2017: Zymeworks Announces the Successful Achievement of a Research Milestone with Lilly in Bispecific Antibody Collaboration 68Dec 15, 2016: Lilly Provides 2017 Financial Guidance And 2016 Update, Reaffirms Financial Expectations Through The Remainder Of The Decade 69Dec 13, 2016: Lilly Announces Program To Provide Insulin At Discounted Prices 71Dec 13, 2016: Blink Health Announces Lilly Insulin Patient Access Program 72Section 6 Appendix 73Methodology 73Ratio Definitions 73About GlobalData 77Contact Us 77Disclaimer 77 6

7 List Of Tables in Eli Lilly and Company (LLY) - Financial and Strategic SWOT Analysis Review [Report Updated: ] List of Tables Eli Lilly and Company, Key Facts 6 Eli Lilly and Company, Key Employees 7 Eli Lilly and Company, Key Employee Biographies 9 Eli Lilly and Company, Major Products and Services 10 Eli Lilly and Company, Number of Pipeline Products by Therapy Area 13 Eli Lilly and Company, Number of Pipeline Products by Therapy Area (Cont...1) 14 Eli Lilly and Company, Number of Pipeline Products by Development Stage 15 Eli Lilly and Company, History 16 Eli Lilly and Company, Subsidiaries 30 Eli Lilly and Company, Joint Venture 38 Eli Lilly and Company, Key Competitors 47 Eli Lilly and Company, Ratios based on current share price 48 Eli Lilly and Company 49 Eli Lilly and Company (Cont...1) 50 Eli Lilly and Company, Interim Ratios 52 Eli Lilly and Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD Eli Lilly and Company, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD Eli Lilly and Company, Recent Deals Summary 56 Currency Codes 73 Capital Market Ratios 73 Equity Ratios 74 Profitability Ratios 74 Cost Ratios 75 Liquidity Ratios 75 Leverage Ratios 76 Efficiency Ratios 76 7

8 List Of Figures, Charts and Diagrams in Eli Lilly and Company (LLY) - Financial and Strategic SWOT Analysis Review [Report Updated: ] List of Figures Eli Lilly and Company, Pipeline Products by Therapy Area 13 Eli Lilly and Company, Pipeline Products by Development Phase 15 Eli Lilly and Company, Performance Chart ( ) 51 Eli Lilly and Company, Ratio Charts 53 Eli Lilly and Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD Eli Lilly and Company, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD

9 How to Buy... Eli Lilly and Company (LLY) - Financial and Strategic SWOT Analysis Review [Report Updated: ] Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0) We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $125 Single User Price $250 Site License Price $375 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will you the invoice with a payment link) Direct Wire Transfer (we will you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0) We will be delighted to give you our personal attention. 9